Protocol for the ELISPOT-TC Trial: A Randomized Controlled Study Evaluating CMV-Specific Cellular Immune Monitoring in Heart Transplant Recipients

García-Romero, Elena; Diez-López, Carles; Kervella, Delphine; Donoso, Victor; García-Cosio, María-Dolores; Ortiz-Bautista, Carlos; Hernández-Pérez, Francisco-José; Couto-Mallon, David; González-Vilchez, Francisco; de-la-Fuente-galan, Luis; López-López, Laura; Grande-Trillo, Antonio; Gómez-Molina, Miriam; Catalá, Pablo; Herrador, Lorena; Rosenfeld, Laia; Ibáñez, Silvia; Donadeu, Laura; Sabe, Nuria; Comin-Colet, Josep; Bestard, Oriol; González-Costello, José

RICSMUR Principal
→
02. Servicio Murciano de Salud (SMS)
→
02.01. Área de Salud I Murcia Oeste
→
02.01.01. Investigación y comunicación científica
→
Ver ítem

dc.contributor.author	García-Romero, Elena
dc.contributor.author	Diez-López, Carles
dc.contributor.author	Kervella, Delphine
dc.contributor.author	Donoso, Victor
dc.contributor.author	García-Cosio, María-Dolores
dc.contributor.author	Ortiz-Bautista, Carlos
dc.contributor.author	Hernández-Pérez, Francisco-José
dc.contributor.author	Couto-Mallon, David
dc.contributor.author	González-Vilchez, Francisco
dc.contributor.author	de-la-Fuente-galan, Luis
dc.contributor.author	López-López, Laura
dc.contributor.author	Grande-Trillo, Antonio
dc.contributor.author	Gómez-Molina, Miriam
dc.contributor.author	Catalá, Pablo
dc.contributor.author	Herrador, Lorena
dc.contributor.author	Rosenfeld, Laia
dc.contributor.author	Ibáñez, Silvia
dc.contributor.author	Donadeu, Laura
dc.contributor.author	Sabe, Nuria
dc.contributor.author	Comin-Colet, Josep
dc.contributor.author	Bestard, Oriol
dc.contributor.author	González-Costello, José
dc.date.accessioned	2026-03-09T08:30:24Z
dc.date.available	2026-03-09T08:30:24Z
dc.date.issued	2025-11-27
dc.identifier.citation	García-Romero E, Díez-López C, Kervella D, Donoso V, García-Cosío MD, Ortiz-Bautista C, et al. Protocol for the ELISPOT-TC Trial: A Randomized Controlled Study Evaluating CMV-Specific Cellular Immune Monitoring in Heart Transplant Recipients. Transpl Int. 27 de noviembre de 2025;38:15565. doi:10.3389/ti.2025.15565
dc.identifier.issn	0934-0874
dc.identifier.uri	https://sms.carm.es/ricsmur/handle/123456789/24979
dc.language.iso	eng
dc.publisher	FRONTIERS MEDIA SA
dc.rights	Atribución/Reconocimiento 4.0 Internacional
dc.rights.uri	https://creativecommons.org/licenses/by/4.0/deed.es
dc.title	Protocol for the ELISPOT-TC Trial: A Randomized Controlled Study Evaluating CMV-Specific Cellular Immune Monitoring in Heart Transplant Recipients
dc.type	info:eu-repo/semantics/article
dc.identifier.pmid	41394517
dc.relation.publisherversion	https://www.frontierspartnerships.org/articles/10.3389/ti.2025.15565/full
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.identifier.doi	10.3389/ti.2025.15565
dc.journal.title	Transplant International
dc.identifier.essn	1432-2277